NanoPass Technologies Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$6M
- Investors
-
9
NanoPass Technologies General Information
Description
Developer of a micro-needle-based intradermal delivery device designed to improve drug, vaccine, and aesthetic administration. The company offers a microneedle platform featuring painless intradermal delivery, micrometric precision in dosage, and consistent penetration supported by manufactured hollow structures, enabling clinicians and healthcare organizations to achieve patient comfort, greater accuracy in therapeutic administration, improved compliance, and broader applicability across vaccines, drugs, and aesthetic treatments.
Contact Information
Website
www.nanopass.comCorporate Office
- 3 Golda Meir Street
- Floor 3
- Nes Ziona 7403648
- Israel
Corporate Office
- 3 Golda Meir Street
- Floor 3
- Nes Ziona 7403648
- Israel
NanoPass Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 15-Jul-2024 | $6M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | 01-Jun-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 01-May-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 25-Apr-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 30-Jul-2012 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 14-Feb-2007 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Seed Round | 01-Apr-2000 | Completed | Startup |
NanoPass Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Preferred | ||||||||
| B Preferred | ||||||||
| A Preferred | 2,000,000 | $0.010000 | $0.81 | $0.81 | 1x | $0.81 | 15.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NanoPass Technologies Comparisons
Industry
Financing
Details
NanoPass Technologies Competitors (14)
One of NanoPass Technologies’s 14 competitors is SHL Medical, a Private Equity-Backed company based in Zug, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SHL Medical | Private Equity-Backed | Zug, Switzerland | ||||
| Vaxxas | Venture Capital-Backed | Hamilton, Australia | ||||
| Uneedle | Venture Capital-Backed | Enschede, Netherlands | ||||
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| Credence MedSystems | Venture Capital-Backed | Menlo Park, CA |
NanoPass Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NanoPass Technologies Patents
NanoPass Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4176921-A1 | Injection configuration with modified luer connector for reduced dead space | Pending | 08-Nov-2021 | ||
| EP-4124355-A1 | Silicon microneedle structure and production method | Active | 29-Jul-2021 | ||
| EP-4124355-B1 | Silicon microneedle structure and production method | Active | 29-Jul-2021 | ||
| EP-4376932-A1 | Silicon microneedle structure and production method | Inactive | 29-Jul-2021 | ||
| EP-2806939-A2 | Microneedle adapter for dosed drug delivery devices | Inactive | 24-Jan-2012 | A61M5/24 |
NanoPass Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NanoPass Technologies Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Awz Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| West Pharmaceutical Services | Corporation | Minority | ||
| D Capital Partners | Investment Bank | Minority | ||
| Elcam Medical | Corporation | Minority |
NanoPass Technologies FAQs
-
When was NanoPass Technologies founded?
NanoPass Technologies was founded in 2000.
-
Where is NanoPass Technologies headquartered?
NanoPass Technologies is headquartered in Nes Ziona, Israel.
-
What is the size of NanoPass Technologies?
NanoPass Technologies has 20 total employees.
-
What industry is NanoPass Technologies in?
NanoPass Technologies’s primary industry is Drug Delivery.
-
Is NanoPass Technologies a private or public company?
NanoPass Technologies is a Private company.
-
What is NanoPass Technologies’s current revenue?
The current revenue for NanoPass Technologies is .
-
How much funding has NanoPass Technologies raised over time?
NanoPass Technologies has raised $18.9M.
-
Who are NanoPass Technologies’s investors?
Awz Ventures, , West Pharmaceutical Services, D Capital Partners, and Elcam Medical are 5 of 9 investors who have invested in NanoPass Technologies.
-
Who are NanoPass Technologies’s competitors?
SHL Medical, Vaxxas, Uneedle, Medherant, and Credence MedSystems are some of the 14 competitors of NanoPass Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
